Holiday Blawg

How does one put the “merry” into Merry Christmas or the “happy” into Happy Holidays when your Mother has received a diagnosis of DLBCL (Diffuse Large-B-Cell Lymphoma) two weeks before Christmas?

I recently wrote about the seemingly dismissive attitudes of doctors when dealing with intermittent symptoms from my otherwise healthy 89-year-old mother. Mom has had a pain in a specific spot in her back for over a year. In her doctor’s defense, she has had her share of diagnostic tests that did not reveal any abnormalities. BUT she has also been rushed to the hospital several times when the pain became too severe to tolerate. She’s been told the pain stemmed from arthritic changes - even though the spot was sensitive to the touch and not achy bone pain. Doctors also suggested that the pain was possibly psychosomatic (ie. in her mind). Only when the tumor screamed out, “Hey, look at me!” and she experienced 3 pleural effusions resulting in 3 thoracenteses (lung tap to remove fluid) did the doctors start to suspect something more serious.

When fluid accumulates in areas of the body where it doesn’t belong, it can be a sign of a malignancy. Mom is a 27-year breast cancer survivor, having had a mastectomy without any other treatment. This fluid was on the side of her mastectomy. After 2 lung taps that did not show any significant pathology, I suggested to the doctor that he order a PET scan. Well, Medicare had the last word on that request: “Not indicated - not paying”. The pain persisted and the fluid kept coming. Finally, on the last CTA a 7 cm pleural paraenchymal mass was detected and biopsied. I expected to hear that my mother has a distant metastasis of her breast cancer, but I was wrong.

DLBCL is a very aggressive form of cancer. Mom’s oncologist suspects that the spot that she persistently complained about was the cancer presenting itself almost a year ago. NOW they would like to get a PET scan to see the involvement in other areas. I’m not trying to play Monday quarterback here but how much responsibility lies with the patient to push for more testing? And it seems that Medicare has the final word anyway.

Holiday cheer is hard to come by in my house at the moment. I’m normally a person that takes on adverse situations and tries to find a silver lining or acceptance. My Mom’s attitude is amazing and certainly helping the rest of us. She has some difficult decisions and perhaps a rough road ahead. I’m afraid that this situation may forever shape our Holiday memories. My advice is to give your Mom a hug and tell her you love her. Life is full of surprises and sometimes it’s not in the form of a wrapped present under the tree.

Susan Beausang, 4women.com

Blog Category: 

More Articles

More Articles

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

In a large trial of older, newly diagnosed patients with chronic lymphocytic leukemia (CLL),...

Today’s typical treatments have been unable to cure numerous types of lymphoma, but emerging immunotherapies could provide the key to...

Biotech firm Gilead Sciences Inc. has announced that the first patient has been dosed in a Phase III trial evaluating the safety and efficacy of...

Last week at the 54th American Society of Hematology Annual Meeting and Exposition in Atlanta, researchers out of MD Anderson Cancer Center in...

The results of a pair of long-term survival studies indicate the therapeutic value of BEXXAR (...

A new lab test that can improve survival rates among patients with chronic lymphocytic leukemia (...

Aggressive Non-Hodgkin’s Lymphomas (NHLs) are fast growing cancers (as opposed to indolent cancers). They involve...

A B cell is a type of lymphocyte that produces antibodies to fight infections. These are the most prevalent lymphocytes in the bloodstream and are...

Sitemap